Why a Complete GLP‑1 RA Drugs List Matters
Many GLP‑1 options use different brand names and dosing formats. That variety can cause confusion and dosing mistakes. Medication‑error reports for GLP‑1 receptor agonists rose sharply from late 2022 (PMC study on GLP‑1 medication errors). Poison‑center calls for semaglutide climbed 38% in 2023, mostly tied to preventable dosing errors (Drug Topics report).
A single, authoritative GLP‑1 RA drugs list reduces confusion and helps prevent basic errors. Pharmacists point to common mix‑ups, like confusing prefilled pens with compounded formulations (Beckers Hospital Review). Adherence is also a challenge; one study found only 47% of patients remained on semaglutide at six months, and 29% at one year (Synapse PatSnap).
Next, we’ll list each GLP‑1 RA, its dosing formats, tracking notes, and what to log for clinician visits. Pepio helps you keep dose history, injection sites, and symptoms organized: the free web tools focus on logging and calculators with privacy‑first local storage in your browser, while reminders and push notifications are provided by the Pepio iOS app. Pepio does not provide medical advice. Track your next shot in Pepio and use the list that follows to capture the right details for follow‑ups.
Top 8 GLP‑1 Receptor Agonist Options
Below is a concise list of GLP‑1 and GLP‑1/GIP medications and what to track for each. Here are eight commonly used options, per Endocrinology Advisor, and the FDA approved a generic liraglutide in December 2024 (FDA press release).
Track all of these with Pepio: Free web trackers (local storage, no sign‑up) + iOS app for reminders, long‑term history, trend charts, and PDF export.
-
Ozempic (semaglutide) — Ozempic is a once‑weekly injectable for type‑2 diabetes, typically dosed at about 0.5–2 mg weekly (Drugs.com). Log weekly shot dates, any dose escalations, and gastrointestinal side effects; share the timeline with your prescriber.
-
Wegovy (semaglutide) — Wegovy is a higher‑dose weekly formulation for chronic weight management, titrated up to 2.4 mg weekly (GoodRx). Track weight trends, appetite changes, and each dose step so your clinician can review progress and titration history.
-
Zepbound (tirzepatide) — Zepbound is a dual GLP‑1/GIP agonist approved for chronic weight management (obesity/overweight) with weekly doses from 2.5–15 mg (GoodRx). Monitor dose increases and nausea patterns, and record weight and appetite so your clinician can correlate symptoms with dose changes.
-
Mounjaro (tirzepatide) — Mounjaro is the brand of tirzepatide marketed for type‑2 diabetes, with dosing up to 15 mg weekly (Endocrinology Advisor). Record injection dates, any glucose trend notes you collect, and symptom timing to support follow‑up conversations.
-
Rybelsus (oral semaglutide) — Rybelsus is the first oral GLP‑1 RA, taken daily in doses ranging from 3 mg to 14 mg (Drugs.com). Track daily adherence and gastrointestinal symptoms; users using Pepio keep clearer daily logs that simplify clinic visits.
-
Trulicity (dulaglutide) — Trulicity is a once‑weekly injectable commonly dosed at 0.75 mg, 1.5 mg, 3.0 mg, or 4.5 mg for diabetes (Drugs.com). Track weekly injection dates and any injection‑site reactions; a concise injection history helps your clinician review tolerance.
-
Victoza (liraglutide) — Victoza is a daily injectable for diabetes at about 0.6–1.8 mg (Drugs.com). Log daily dose, appetite notes, and side effects so your prescriber can confirm your medication history and discuss next steps.
-
Saxenda (liraglutide 3 mg) — Saxenda is the higher‑dose liraglutide formulation approved for chronic weight management (3 mg daily). A generic liraglutide became available in late 2024 (FDA press release). Track weight, appetite, and daily dosing for clearer clinician conversations.
What to track across these options
Key tracking points for every GLP‑1 RA:
- Shot or pill dates and exact dose taken.
- Any dose escalations or missed doses.
- Gastrointestinal symptoms and their timing.
- Weight, appetite, and “food noise” changes.
- Injection‑site location for injectables.
Why tracking matters
Why consistent tracking matters:
- A clean log shows patterns your clinician can review.
- Notes on timing link symptoms to specific doses.
- Recorded weight trends help assess progress over time.
Sources and further reading
- For a full class overview and the current list of agents, see Endocrinology Advisor.
- For dosing formats and route details, see Drugs.com.
- For recent market changes like the generic liraglutide approval, see the FDA press release.
- For indication and weight‑loss approvals across agents, see GoodRx. Track weight, appetite, and daily dosing details to share with your clinician.
- A concise agent list is also available from JoinCalibrate.
Keeping an organized record makes clinic visits smoother. Pepio’s approach helps you collect the exact fields clinicians ask about, like dose history and symptom timing. Learn more about Pepio’s approach to GLP‑1 and peptide tracking to keep your routine and notes in one place.
Disclaimer: Pepio is for organization and self‑tracking only. Pepio does not provide medical advice, dosing recommendations, diagnosis, or treatment. Always follow instructions from your clinician, prescriber, pharmacist, or medication label.
A clear GLP‑1 drugs list and consistent tracking reduce confusion and make clinician conversations clearer. Long‑term adherence remains a challenge for many users (Synapse PatSnap Adherence Study 2024). Dosing mistakes have also driven a rise in poison‑center calls, highlighting the need for better recordkeeping (Drug Topics Report on Poison‑Center Calls 2024). A short, repeatable framework turns scattered notes into a useful record.
Use this 4‑step tracking framework as your quick action plan.
- Log: record the dose, date, time, and injection site after every shot.
- Review: check trends in symptoms, appetite, and weight at regular intervals.
- Adjust (with your clinician): bring organized notes to discuss any dosing or symptom concerns.
- Share: prepare clear, concise records for follow‑up visits.
Pepio helps you keep dose history, reminders, symptoms, and injection sites in one place. Users who organize routines with Pepio report clearer notes for appointments and fewer gaps in their logs. Learn more about Pepio's approach to organizing GLP‑1 routines and see how it can fit your habit. Always follow your clinician, prescriber, or pharmacist instructions and bring organized notes to your next visit.